Stanley R. Frankel's most recent trade in Precision Biosciences Inc was a trade of 9,826 Restricted Stock Units done . Disclosure was reported to the exchange on June 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Stanley R. Frankel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,202 | 0 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Stanley R. Frankel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,202 | 4,252 (0%) | 0% | - | Common Stock | |
Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 126,075 | 126,075 | - | - | Restricted Stock Units | |
Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 156,951 | 156,951 | - | - | Stock Option (Right to Buy) | |
Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 63,325 | 63,325 | - | - | Stock Option (Right to Buy) |